42000101
PRONOVA® UP MVG
medium viscosity sodium alginate, viscosity >200 mPa.s, 1 %(20 °C)(low), guluronate monomer units ≥60 %
别名:
High Molecular Weight TM=["PRONOVA"] UP
form
powder
mol wt
Mw >200 kDa (approximate)
composition
guluronate monomer units, ≥60% , G/M ratio, ≥1.5
impurities
≤100 CFU/g Total viable count, ≤100 EU/g Endotoxins
pH
5.5-8.5 (20 °C, 1% in water)
viscosity
>200 mPa.s, 1 %(20 °C) (
low)
Quality Level
General description
PRONOVA UP MVG is a medium viscosity (greater than 200 mPas) sodium alginate where minimum 60% of the monomer units are guluronate.
Application
Examples of Pronova Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.
Legal Information
Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.
Disclaimer
NOT FOR USE IN HUMANS
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
商品
Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持